Spyre Therapeutics(SYRE) - Prospectus(update)

Table of Contents As filed with the Securities and Exchange Commission on October 6, 2023 Registration No. 333-273769 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 ON FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aeglea BioTherapeutics, Inc. If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following bo ...